Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature

Hepatology

Volumn 45, Issue 6, 2007, Pages 1547-1554

  Björnsson, Einar ^a   Chari, Suresh T ^b   Smyrk, Thomas C ^b   Lindor, Keith ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID;

AUTOIMMUNE PANCREATITIS; BILE DUCT CARCINOMA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; MEDICAL LITERATURE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

BILE DUCTS; CHOLANGITIS, SCLEROSING; HUMANS; IMMUNOGLOBULIN G; TERMINOLOGY;

EID: 34250318195     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21685     Document Type: Review

References (64)

1. Bartholomew LG, Cain JC, Woolner LB, Utz DC, Ferris DO. Sclerosing cholangitis: its possible association with Riedel's struma and fibrous retroperitonitis. Report of two cases. N Engl J Med 1963;269:8-12.
2. Wenger J, Gingrich GW. Mendeloff J. Sclerosing cholangitis - a manifestation of systemic disease. Increased serum gamma-globulin, follicular lymph node hyperplasia, and orbital pseudotumor. Arch Intern Med 1965; 116:509-514.
3. Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel's thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med 1967;66:884-892.
4. Waldram R, Kopelman H, Tsantoulas D, Williams R. Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two siblings. Lancet 1975; 1:550-552.
5. Sjogren I, Wengle B, Korsgren M. Primary sclerosing cholangitis associated with fibrosis of the submandibular glands and the pancreas. Acta Med Scand 1979;205:139-141.
6. Rennet IG, Ponto GC, Savage WT 3rd, Boswell WD. Idiopathic retroperitoneal fibrosis producing common bile duct and pancreatic duct obstruction. Gastroenterology 1980;79:348-351.
7. Scully RE, Mark EJ, Mcneely BU. Case records of the Massachusetts general hospital (case 6 1982). NEJM 1982;306: 49-358.
8. Gurian LE, Keeffe EB. Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. Gastroenterology 1982;82:581-585.
9. Jafri SZ, Bree RL, Agha FP, Schwab RE. Inflammatory pseudotumor from sclerosing cholangitis. J Comput Assist Tomogr 1983;7:902-904.
10. Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex. Am J Surg 1984;147:822-826.
11. Versapuech JM, Labayle D, Grange D, Fischer D, Kemeny F, D'Hubert E. Sclerosing cholangitis, chronic pancreatitis and Sjogren's syndrome. Ann Med Intern 1986;137:147-151.
12. Nakanuma Y, Kato Y, Unoura M, Kobayashi K, Yamamoto M. An autopsy case of primary sclerosing cholangitis with sequential histologic observations of the liver. Acta Pathol Jpn 1988;38:249-257.
13. Laszik GZ, Pap A, Farkas G. A case of primary sclerosing cholangitis mimicking chronic pancreatitis. Int J Pancreatol 1988;3:503-508.
14. Clark A, Zeman RK, Choyke PL, White EM, Burrell MI, Grant EG, et al. Pancreatic pseudotumors associated with multifocal idiopathic fibrosclerosis. Gastrointest Radiol 1988;13:30-32.
15. Barreda F, Contardo C, Leon A, Navarrete J, Figueroa R, Attanasio F. Primary sclerosing cholangitis associated with Sjogren's syndrome, retroperitoneal fibrosis and chronic pancreatitis. Report of a case. Rev Gastroenterol Peru 1989;9:106-114.
16. Bastid C, Sahel J, Sarles H. Spontaneous healing of sclerosing cholangitis associated with stricture of the main pancreatic duct. Pancreas 1990;5:489-492.
17. Goldin E, Libson E, Wengrower D, Antal S, Kovacs Z, Rachmilewitz D. Severe acute pancreatitis as the presenting symptom of primary sclerosing cholangitis: treatment by endoscopic insertion of a biliary stent. Int Surg 1990;75:58-60.
18. Sood GK, Vij JC, Mohapatra JR, Baijal SS, Broor SL. Primary sclerosing cholangitis with chronic pancreatitis. Indian J Gastroenterol 1990;9:309-310.
19. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387-395.
20. Laitt RD, Hubscher SG, Buckels JA, Darby S, Elias E. Sclerosing cholangitis associated with multifocal fibrosis: a case report. Gut 1992;33:1430-1432.
21. Kyokane K, Ichihara T, Horisawa M, Suzuki N, Ichihara S, Suga S, et al. Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid. Hepatogastroenterology 1994;41:449-452.
22. Chutaputti A, Burrell MI, Boyer JL. Pseudotumor of the pancreas associated with retroperitoneal fibrosis: a dramatic response to corticosteroid therapy. Am J Gastroenterol 1995;90:1155-1158.
23. Stathopoulos G, Nourmand AD, Blackstone M, Andersen D, Baker AL. Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor. J Clin Gastroenterol 1995;21:143-148.
24. Beck A, Bohnert M, Lesch R, Schmid U, Roth E. A radiologically unclassifiable pancreatic tumor: pseudotumorous nodular lymphoplasmacellular pancreatitis. A special form of retroperitoneal fibrosis? Rontgenpraxis 1996;49:85-89.
25. Pohl R, Junge U. Primary sclerosing cholangitis with chronic pancreatitis. Dtsch Med Wochenschr 1997;122:778-782.
26. Pineau BC, Pattee LP, McGuire S, Sekar A, Scully LJ. Unusual presentation of primary sclerosing cholangitis. Can J Gastroenterol 1997;11:45-48.
27. Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997;41:263-268.
28. Nieminen U, Koivisto T, Kahri A, Farkkila M. Sjogren's syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations. Am J Gastroenterol 1997;92:139-142.
29. Levey JM, Mathai J. Diffuse pancreatic fibrosis: an uncommon feature of multifocal idiopathic fibrosclerosis. Am J Gastroenterol 1998;93:640-642.
30. Kazumori H, Ashizawa N, Moriyama N, Arima N, Hirakawa K, Adachi K, et al. Primary sclerosing pancreatitis and cholangitis. Int J Pancreatol 1998; 24:123-127.
31. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999;354:43-44.
32. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573-581.
33. Horiuchi A, Kawa S, Hamano H, Ochi Y, Kiyosawa K. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: report of 2 case reports and review. Gastrointest Endosc 2001;53:518-522.
34. Nakazawa T, Ohara H, Yamada T, Ando H, Sano H, Kajino S, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001;48:625-630.
35. Kram MT, May LD, Cooperman A, Bernstein S, Abedeer R, Cohen PR. Lymphoplasmacytic sclerosing pancreatitis and cholangitis. Gastrointest Endosc 2002;55:588-590.
36. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494-499.
37. Ichimura T, Kondo S, Ambo Y, Hirano S, Ohmi M, Okushiba S, et al. Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology 2002;49:1221-1224.
38. Kuroiwa T, Suda T, Takahashi T, Hirono H, Natsui M, Motoyama H, et al. Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig Dis Sci 2002;47:1810-1816.
39. Fernandez-del Castillo CF, Sahani DV, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med 2003;349:893-901.
40. Hirano K, Shiratori Y, Komatsu Y, Yamamoto N, Sasahira N, Toda N, et al Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003;1:453-464.
41. Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: Case report and review. Gastrointest Endosc 2003;57:118-120.
42. Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003;38:603-607.
43. Toosi MN, Heathcote J. Pancreatic pseudotumor with sclerosing pancreato-cholangitis: is this a systemic disease? Am J Gastroenterol 2004;99: 377-882.
44. Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004;60:937-944.
45. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28:1193-1203.
46. Prasad P, Salem RR, Mangla R, Aslanian H, Jain D, Lee J. Lymphoplasmacytic sclerosing pancreato-cholangitis: a case report and review of the literature. Yale J Biol Med 2004;77:143-148.
47. Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004;29:153-159.
48. Nishino T, Toki F, Oyama H, Oi I, Kobayashi M, Takasaki K, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005;30:76-82.
49. Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005;30:20-25.
50. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc 2005;62:152-157.
51. Fukui T, Okazaki K, Yoshizawa H, Ohashi S, Tamaki H, Kawasaki K, et al. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren's syndrome. Pancreatology 2005; 5:86-91.
52. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'. Pathol Int 2005;55:405-411.
53. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-relared sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006;6:132-137.
54. van Buuren HR, Vleggaar FP, Willemien Erkelens G, Zondervan PE, Lesterhuis W, Van Eijck CH, et al. Autoimmune pancreatocholangitis: A series often patients. Scand J Gastroenterol Suppl 2006;243:70-78.
55. Yoshida K, Toki F, Takeuchi T, Waranabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-158.
56. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738.
57. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience. Clin Gastroenterol Hepatol 2006;4:1010-1016.
58. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis. Am J Gastroenterol 2006;4:1010-1016.
59. Angulo P, Lindor KD. Primary sclerosing cholangitis. HEPATOLOGY 1999; 30:325-332.
60. Shirakata Y, Shiraishi S, Sayama K, Miki Y. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol 1990; 17:661-666.
61. Bjornsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999;19:501-508.
62. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-reIated autoimmune disease. J Gastroenterol 2003;38:982-984.
63. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004;99:523-526.
64. Chen W, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst Rev 2004;3:CD004036.